Mostrando 1,461 - 1,480 Resultados de 56,791 Para Buscar '"pneumonia"', tiempo de consulta: 0.32s Limitar resultados
  1. 1461
    “…BACKGROUND: Rapid identification of causative organisms and tailored antibiotic therapy is essential to improving patient outcomes in critically ill patients with nosocomial pneumonia (NP). The BioFire (®) FilmArray (®) Pneumonia Panel (BFPP) can identify and semi-quantify the causative organisms via PCR. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 1462
  3. 1463
    “…To investigate the relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia (RMPP) in children. Serum levels of LncRNA NNT-AS1 of RMPP and non-RMPP (NRMPP) patients were detected by real-time PCR, and were analyzed together with serum c-reactive protein (CRP) and procalcitonin (PCT). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 1464
    “…His HRCT findings had atypically developed from a probable usual interstitial pneumonia pattern to a nonspecific interstitial pneumonia (NSIP) like pattern over 6 years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 1465
    “…OBJECTIVE: Thise study is aimed to identify the biomarkers for predicting refractory Mycoplasma pneumoniae pneumonia in Chinese children at the time of the hospital admission. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 1466
    por Jang, Min Sik, Kim, Bit Gyeol, Kim, Jihye
    Publicado 2021
    “…OBJECTIVE: To identify patients with Mycoplasma pneumoniae pneumonia (MPP) with a risk of prolonged fever while on macrolides. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 1467
    “…OBJECTIVE: The aim of this study was to compare the usefulness of cefoperazone-sulbactam and that of piperacillin-tazobactam in the treatment of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 1468
    “…BACKGROUND: A predictive model for risk of Mycoplasma pneumoniae (MP)-related hepatitis in MP pneumonia pediatric patients can improve treatment selection and therapeutic effect. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 1469
    “…BACKGROUND: How to early distinguish the severity of Mycoplasma pneumoniae pneumonia (MPP) is a worldwide concern in clinical practice. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 1470
    por Fu, Xilin, Yang, Ningfei, Ji, Jianwei
    Publicado 2021
    “…OBJECTIVE: Use of optimal Atlas segmentation algorithm to study the imaging signs of mycoplasma pneumonia with multi-slice spiral CT (HRCT), and to explore the value of HRCT in the diagnosis and efficacy in evaluation of mycoplasma pneumonia in children. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 1471
  12. 1472
  13. 1473
  14. 1474
  15. 1475
    por Cao, Xinying
    Publicado 2022
    “…The goal of this study was to see how important it is to monitor Mycoplasma pneumoniae-specific antibody IgM, C-reactive protein, and procalcitonin levels in the blood of kids with Mycoplasma pneumoniae pneumonia as a reference for clinical diagnosis and treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 1476
    “…Results: The first identified CRE-positive patient was admitted to the new unit on December 4, 2020; urine culture obtained at the time of admission grew KPC–producing Klebsiella pneumoniae (KPC-KP). The sink in this patient’s room had been sampled 3 prior times (most recently on November 9, 2020) and was negative for CRE. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 1477
    “…BACKGROUND: Antimicrobial resistance (AMR), including multidrug (MDR) and extensively drug-resistant (XDR) bacteria, is an essential consideration in the prevention and management of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 1478
    “…Gram staining of the sputum revealed a large number of gram-negative diplococci phagocytosed by many neutrophils, and a diagnosis of bacterial pneumonia was established. The culture yielded non-serogroupable N. meningitidis, and the patient was diagnosed with non-serogroupable N. meningitidis pneumonia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 1479
    por Martin, Helena, Falconer, Jennifer, Addo-Yobo, Emmanuel, Aneja, Satinder, Arroyo, Luis Martinez, Asghar, Rai, Awasthi, Shally, Banajeh, Salem, Bari, Abdul, Basnet, Sudha, Bavdekar, Ashish, Bhandari, Nita, Bhatnagar, Shinjini, Bhutta, Zulfiqar A, Brooks, Abdullah, Chadha, Mandeep, Chisaka, Noel, Chou, Monidarin, Clara, Alexey W, Colbourn, Tim, Cutland, Clare, D'Acremont, Valérie, Echavarria, Marcela, Gentile, Angela, Gessner, Brad, Gregory, Christopher J., Hazir, Tabish, Hibberd, Patricia L., Hirve, Siddhivinayak, Hooli, Shubhada, Iqbal, Imran, Jeena, Prakash, Kartasasmita, Cissy B, King, Carina, Libster, Romina, Lodha, Rakesh, Lozano, Juan M, Lucero, Marilla, Lufesi, Norman, MacLeod, William B, Madhi, Shabir Ahmed, Mathew, Joseph L, Maulen-Radovan, Irene, McCollum, Eric D, Mino, Greta, Mwansambo, Charles, Neuman, Mark I, Nguyen, Ngoc Tuong Vy, Nunes, Marta C, Nymadawa, Pagbajabyn, O'Grady, Kerry-Ann F, Pape, Jean-William, Paranhos-Baccala, Glaucia, Patel, Archana, Picot, Valentina Sanchez, Rakoto-Andrianarivelo, Mala, Rasmussen, Zeba, Rouzier, Vanessa, Russomando, Graciela, Ruvinsky, Raul O, Sadruddin, Salim, Saha, Samir K., Santosham, Mathuram, Singhi, Sunit, Soofi, Sajid, Strand, Tor A, Sylla, Mariam, Thamthitiwat, Somsak, Thea, Donald M, Turner, Claudia, Vanhems, Philippe, Wadhwa, Nitya, Wang, Jianwei, Zaman, Syed MA, Campbell, Harry, Nair, Harish, Qazi, Shamim Ahmad, Nisar, Yasir Bin
    Publicado 2022
    “…BACKGROUND: The existing World Health Organization (WHO) pneumonia case management guidelines rely on clinical symptoms and signs for identifying, classifying, and treating pneumonia in children up to 5 years old. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 1480
    “…Mycoplasma pneumoniae (MP) is an important human pathogen that mainly affects children causing general and severe Mycoplasma pneumoniae pneumonia (G/SMPP). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS